Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
51 results
  • Breast Cancer

17-521          Phase III

A Double-Blind, Placebo-Controlled, Randomized, Phase III Study of Ipataserib in Combination with Paclitaxel as a Treatment for Patients with PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer (View details on clinicaltrial.gov)

  • Breast Cancer

18-084          Phase II

A Multi-center, Open-label, Phase 2 Clinical Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of DHP107 (Liporaxel, Oral Paclitaxel) Compared to IV Paclitaxel in Patients with Recurrent or Metastatic Breast Cancer (View details on clinicaltrial.gov)

  • Ovarian Cancer, Breast Cancer, Bladder Cancer, Endometrial Cancer

17-392          Phase I

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-033, an Anti-LAG-3 Monoclonal Antibody, Alone and in Combination With an Anti-PD-1 in Patients With Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Ovarian Cancer, Lung Cancer, Endometrial Cancer, Breast Cancer

16-393          Phase I

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Breast Cancer

17-285          Phase I

A phase 1 study of the CDK4/6 inhibitor ribociclib (LEE011) in combination with the PD-1 inhibitor PDR001 in patients with metastatic hormone receptor-positive breast cancer and metastatic ovarian cancer (View details on clinicaltrial.gov)

  • Merkel Cell Carcinoma, Metastatic/Advanced Cancer, Breast Cancer, Head and Neck Cancer, Melanoma

17-334          Phase I

A Phase 1, Open-Label, Multicenter, Dose Escalation Study or MRNA-2416, A Lipid Nanoparticle Encapsulated MRNA Encoding Human OX4OL, For Intratumoral Injection to Patients with Advanced Malignancies (View details on clinicaltrial.gov)

  • Breast Cancer

17-371          Phase II

A Phase 1/2 study for the safety, efficacy, pharmacokinetic and pharmacodynamics evaluation of SAR439859, administered orally as monotherapy, then in combination with palbociclib in postmenopausal women with estrogen receptor-positive advanced breast cancer (View details on clinicaltrial.gov)

  • Metastatic/Advanced Cancer, Melanoma, Lung Cancer, Kidney Cancer, Breast Cancer, Bladder Cancer

17-310          Phase II

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Dose Expansion Study of NKTR-214 and Nivolumab in Patients with Select Locally Advanced or Metastatic Solid Tumor Malignancies (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Merkel Cell Carcinoma, Lung Cancer, Breast Cancer, Kidney Cancer

18-051          Phase I

A Phase 1a/1b Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of RO7198457 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Tumors (View details on clinicaltrial.gov)

Showing 1 - 10 of 51 results